Global X Genomics & Biotechnology ETF
GNOM
GNOM
38 hedge funds and large institutions have $14.2M invested in Global X Genomics & Biotechnology ETF in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 17 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
65% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 17
Holders
38
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.53M | |
| 2 | +$777K | |
| 3 | +$561K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$408K |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$318K |
Top Sellers
| 1 | -$1.18M | |
| 2 | -$579K | |
| 3 | -$359K | |
| 4 |
OCM
One Capital Management
Westlake Village,
California
|
-$254K |
| 5 |
SAM
Smartleaf Asset Management
Boston,
Massachusetts
|
-$215K |
